Interest of youth living with HIV in long-acting antiretrovirals
JAIDS Journal of Acquired Immune Deficiency Syndromes, 2019•journals.lww.com
Objectives: This study's primary objective was to characterize attitudes to long-acting
antiretrovirals (LAARV), among youth aged 13–24 years living with perinatally acquired HIV
and nonperinatally acquired HIV. Secondary objectives included: assessing whether those
with detectable HIV RNA PCR viral load had higher enthusiasm for LAARV compared to
those with suppressed viral load, and examining characteristics associated with LAARV
enthusiasm. Methods: A cross-sectional survey of 303 youth living with HIV (YHIV) followed …
antiretrovirals (LAARV), among youth aged 13–24 years living with perinatally acquired HIV
and nonperinatally acquired HIV. Secondary objectives included: assessing whether those
with detectable HIV RNA PCR viral load had higher enthusiasm for LAARV compared to
those with suppressed viral load, and examining characteristics associated with LAARV
enthusiasm. Methods: A cross-sectional survey of 303 youth living with HIV (YHIV) followed …
Abstract
Objectives:
This study's primary objective was to characterize attitudes to long-acting antiretrovirals (LAARV), among youth aged 13–24 years living with perinatally acquired HIV and nonperinatally acquired HIV. Secondary objectives included: assessing whether those with detectable HIV RNA PCR viral load had higher enthusiasm for LAARV compared to those with suppressed viral load, and examining characteristics associated with LAARV enthusiasm.
Methods:
A cross-sectional survey of 303 youth living with HIV (YHIV) followed at 4 pediatric/adolescent HIV clinics in the United States was performed to determine interest in LAARV, using a modified survey instrument previously used in adults. Interest in LAARV across groups was compared. Poisson regression with robust variance was used to determine the impact of various characteristics on interest in LAARV.
Findings:
Lippincott Williams & Wilkins